CVE-2026-50034
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
- Record
CVE-2026-50034- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
EUVDEUVD-2026-37971
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
- Record
EUVD-2026-37971- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-cmv8-9pgg-5rx4
An attacker within BLE communication range can passively intercept wireless traffic and obtain...
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
- Record
GHSA-cmv8-9pgg-5rx4- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
NVD
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
- Record
CVE-2026-50034- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-319
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-50034 is a high vulnerability (CVSS 7.1) in Apollo Pharmacy Blood Glucose Monitoring System (model No. Apg-01 Bt), published June 18, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.21%, the 11th percentile. No source names a fixed version.
References
apollopharmacy.in/contact-us
cisa.gov/news-events/news/understanding-bluetooth-technology
github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json
nvd.nist.gov/vuln/detail/CVE-2026-50034